MacroGenics Announces Date of Fourth Quarter 2022 Financial

MacroGenics Announces Date of Fourth Quarter 2022 Financial

ROCKVILLE, MD, March 07, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and......

Additional Data on Lumos OraGrowtH Trials Presented

Additional Data on Lumos OraGrowtH Trials Presented

Oral Presentation Highlighting Data on 15 Subjects from OraGrowtH212 Trial Supportive of Conclusions from Interim Data Analysis Baseline Characteristics......

Aurora Spine Receives IRB Approval To Commence Multicenter

Aurora Spine Receives IRB Approval To Commence Multicenter

CARLSBAD, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer......

Rapid Micro Biosystems to Participate in the Cowen 43rd

Rapid Micro Biosystems to Participate in the Cowen 43rd

LOWELL, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology......

Rapid Micro Biosystems to Announce Fourth Quarter and Full

Rapid Micro Biosystems to Announce Fourth Quarter and Full

LOWELL, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology......

MacroGenics to Participate in Upcoming Investor

MacroGenics to Participate in Upcoming Investor

ROCKVILLE, MD, Feb. 06, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing......

menu
menu